A Clinical Study of Boserolimab (MK-5890) with Pembrolizumab and Chemotherapy in People with Early Triple-Negative Breast Cancer (MK-5890-003)

Trial Identifier: 5890-003
Sponsor: MSD
Start Date: March 2025
Primary Completion Date: January 2029
Study Completion Date: March 2031
Condition: Breast Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

No locations posted.